v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 271,497 $ 224,065
Marketable securities 0 46,036
Trade receivables (net of allowance of $3,829 and $6,372) 197,225 168,770
Finance receivables (net of allowance of $29,026 and $4,191) 180,486 139,045
Other current assets 24,295 15,281
Total current assets 673,503 593,197
Property and equipment (net of accumulated depreciation of $6,589 and $5,227) 12,852 7,625
Goodwill 183,725 180,478
Acquired intangible assets (net of amortization of $40,202 and $28,972) 81,024 90,816
Internal-use software costs (net of amortization of $67,874 and $38,499) 81,964 68,571
Other assets 52,543 43,462
Total assets 1,085,611 984,149
Current Liabilities:    
Accounts payable 390,830 345,605
Accrued payroll 9,308 16,725
Accrued other liabilities 20,711 18,836
Total current liabilities 420,849 381,166
Long-term debt 190,000 123,000
Other long-term liabilities 45,079 39,979
Total liabilities 655,928 544,145
Commitments and Contingencies (Note 8)
Stockholders' Equity:    
Preferred stock; $0.001 par value; 20,000 shares authorized; 0 and 0 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively 0 0
Additional paid-in capital 996,628 944,891
Accumulated deficit (568,456) (502,315)
Accumulated other comprehensive income (loss) 1,338 (2,740)
Total stockholders' equity 429,683 440,004
Total liabilities and stockholders' equity 1,085,611 984,149
Common Stock    
Stockholders' Equity:    
Common stock $ 173 $ 168
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common Class B    
Stockholders' Equity:    
Common stock $ 0 $ 0
Common stock, shares authorized (in shares) 0 160,000,000

Source

10-K PDF
XBRL